BioVersys AG (XSWX:BIOV) Effective Interest Rate on Debt %: 5.32% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:BIOV BioVersys AG XSWX:BIOV
4 GF Score
Price CHF27.70
View Full Analysis

What is BioVersys AG Effective Interest Rate on Debt %?

BioVersys AG XSWX:BIOV +0.73% 4 Effective Interest Rate on Debt % is 5.32% as of Dec. 2025. GuruFocus rates XSWX:BIOV with a GF Score™ of 4/100.

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. BioVersys AG's annualized positive value of Interest Expense for the quarter that ended in Dec. 2025 was CHF1.06 Mil. BioVersys AG's average total debt for the quarter that ended in Dec. 2025 was CHF19.99 Mil. Therefore, BioVersys AG's annualized Effective Interest Rate on Debt % for the quarter that ended in Dec. 2025 was 5.32%.

BioVersys AG  (XSWX:BIOV) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.

BioVersys AG Effective Interest Rate on Debt % Related Terms

BioVersys AG Effective Interest Rate on Debt % Historical Data

* Premium members only.

The historical data trend for BioVersys AG's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioVersys AG Effective Interest Rate on Debt % Chart

BioVersys AG Annual Data
Trend Dec24 Dec25
Effective Interest Rate on Debt %
6.11 5.57

BioVersys AG Semi-Annual Data
Jun24 Dec24 Jun25 Dec25
Effective Interest Rate on Debt % 0.00 5.73 6.19 5.32

XSWX:BIOV vs VRTX, REGN, ALNY: Effective Interest Rate on Debt % Comparison

For the Biotechnology subindustry, BioVersys AG's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioVersys AG Effective Interest Rate on Debt % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioVersys AG's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where BioVersys AG's Effective Interest Rate on Debt % falls into.


XSWX:BIOV
4GF Score
BioVersys AG XSWX:BIOV
Effective Interest Rate on Debt % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BioVersys AG Effective Interest Rate on Debt % Calculation

BioVersys AG's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Dec. 2025 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (A: Dec. 2024 )+Total Debt  (A: Dec. 2025 ))/ count )
=-1  *  -1.077/( (16.965+21.729)/ 2 )
=-1  *  -1.077/19.347
=5.57 %

where

Total Debt  (A: Dec. 2024 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=13.761 + 3.204
=16.965

Total Debt  (A: Dec. 2025 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=21.44 + 0.289
=21.729

BioVersys AG's annualized Effective Interest Rate on Debt % for the quarter that ended in Dec. 2025 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (Q: Jun. 2025 )+Total Debt  (Q: Dec. 2025 ))/ count )
=-1  *  -1.064/( (18.247+21.729)/ 2 )
=-1  *  -1.064/19.988
=5.32 %

where

Total Debt  (Q: Jun. 2025 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=14.008 + 4.239
=18.247

Total Debt  (Q: Dec. 2025 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=21.44 + 0.289
=21.729

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is two times the semi-annual (Dec. 2025) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.

What does a Effective Interest Rate on Debt % of 5.32% mean?
BioVersys AG (XSWX:BIOV) has a Effective Interest Rate on Debt % of 5.32% as of Dec. 2025. Effective interest rate on debt is the rate a company actually pays on its debt. View historical data on BioVersys AG and its competitors.
Is BioVersys AG's Effective Interest Rate on Debt % too high?
BioVersys AG's current Effective Interest Rate on Debt % is 5.32%. Overall, BioVersys AG has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does BioVersys AG's Effective Interest Rate on Debt % compare to VRTX and REGN?
BioVersys AG's Effective Interest Rate on Debt % of 5.32% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Effective Interest Rate on Debt % for a Biotechnology company?
A good Effective Interest Rate on Debt % depends on the Biotechnology industry context. However, Effective Interest Rate on Debt % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Effective Interest Rate on Debt % mean?
A high Effective Interest Rate on Debt % can signal that a stock is expensive relative to its fundamentals. Effective interest rate on debt is the rate a company actually pays on its debt. View historical data on BioVersys AG and its competitors. BioVersys AG's current Effective Interest Rate on Debt % is 5.32%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioVersys AG stock overvalued right now?
BioVersys AG (XSWX:BIOV) has a current Effective Interest Rate on Debt % of 5.32%. The current Effective Interest Rate on Debt % is 5.32%. BioVersys AG's overall GF Score™ is 4/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Effective Interest Rate on Debt % calculated?
Effective Interest Rate on Debt % is calculated from a company's financial statements. For BioVersys AG (XSWX:BIOV), the current Effective Interest Rate on Debt % is 5.32% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BioVersys AG Business Description

Other Exchanges BIOVz:UKW33:Germany
Address c/o Technologiepark, Hochbergerstrasse 60c, Basel, CHE, CH-4057
BioVersys AG is a multi-asset, clinical-stage biopharmaceutical company. The Group focuses on research and development of novel antibacterial products for serious life-threatening infections caused by multi-drug resistant (MDR) bacteria. The pipeline products of the company include BV100 - novel MoA, Alpibectir - novel potentiator MoA, BV200 - novel anti-virulence MoA, BV500 - novel series, and others. It has one operating segment focusing on the research and development and prospective commercialization of antibiotics. Geographically, the company operates in Switzerland and France.
4GF Score

Get the complete analysis for XSWX:BIOV

Effective Interest Rate on Debt % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF27.70
Price